These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27059652)

  • 21. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S; Wardemann H; Hammersen J; Tsuiji M; Meffre E; Pascual V; Nussenzweig MC
    J Exp Med; 2005 Mar; 201(5):703-11. PubMed ID: 15738055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
    Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I
    Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
    Kalunian KC; Chatham WW; Massarotti EM; Reyes-Thomas J; Harris C; Furie RA; Chitkara P; Putterman C; Gross RL; Somers EC; Kirou KA; Ramsey-Goldman R; Hsieh C; Buyon JP; Dervieux T; Weinstein A
    Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients.
    Wangriatisak K; Thanadetsuntorn C; Krittayapoositpot T; Leepiyasakulchai C; Suangtamai T; Ngamjanyaporn P; Khowawisetsut L; Khaenam P; Setthaudom C; Pisitkun P; Chootong P
    Arthritis Res Ther; 2021 Jul; 23(1):179. PubMed ID: 34229724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic FOXO1 identifies a novel disease-activity associated B cell phenotype in SLE.
    Hritzo Ahye MK; Golding A
    Lupus Sci Med; 2018; 5(1):e000296. PubMed ID: 30397498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
    Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
    Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
    Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
    Néron S; Boire G; Dussault N; Racine C; de Brum-Fernandes AJ; Côté S; Jacques A
    Arch Immunol Ther Exp (Warsz); 2009; 57(6):447-58. PubMed ID: 19866343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
    Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
    Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of B Cell Tolerance in CVID.
    Richardson CT; Slack MA; Dhillon G; Marcus CZ; Barnard J; Palanichamy A; Sanz I; Looney RJ; Anolik JH
    Front Immunol; 2019; 10():2881. PubMed ID: 31921145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.
    Perniok A; Wedekind F; Herrmann M; Specker C; Schneider M
    Lupus; 1998; 7(2):113-8. PubMed ID: 9541096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype.
    Berggren O; Hagberg N; Alexsson A; Weber G; Rönnblom L; Eloranta ML
    PLoS One; 2017; 12(8):e0183946. PubMed ID: 28846748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
    Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
    Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor expression in lupus peripheral blood mononuclear cells.
    Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Kimura H; Ishibashi H; Eguchi K
    J Rheumatol; 2007 Mar; 34(3):493-500. PubMed ID: 17295441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients.
    Medrano-Campillo P; Sarmiento-Soto H; Álvarez-Sánchez N; Álvarez-Ríos AI; Guerrero JM; Rodríguez-Prieto I; Castillo-Palma MJ; Lardone PJ; Carrillo-Vico A
    J Pineal Res; 2015 Mar; 58(2):219-26. PubMed ID: 25612066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.